Circulatory Levels of RANKL, OPG, and Oxidative Stress Markers in Postmenopausal Women With Normal or Low Bone Mineral Density
Introduction: Receptor activator of nuclear factor κB ligand (RANKL), osteoprotegerin (OPG), and oxidative stress markers are suggested to contribute to bone loss in osteoporosis that occurs in menopause. However, the association between these markers and bone mineral density (BMD) is controversial....
Main Authors: | Fawaz Y Azizieh, Diaa Shehab, Khaled Al Jarallah, Renu Gupta, Raj Raghupathy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-04-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/1177271919843825 |
Similar Items
-
Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD
by: Azizieh FY, et al.
Published: (2019-04-01) -
The Role of Serum Expression Levels of Microrna-21 on Bone Mineral Density in Hypostrogenic Postmenopausal Women with Osteoporosis: Study on Level of RANKL, OPG, TGFβ-1, Sclerostin, RANKL/OPG Ratio, and Physical Activity
by: I Nyoman Suarjana, et al.
Published: (2019-11-01) -
Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis
by: Xiao-Juan Xu, et al.
Published: (2013-01-01) -
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection.
by: Kehmia Titanji, et al.
Published: (2014-10-01) -
"Single nucleotide polymorphisms of the <it>OPG/RANKL </it>system genes in primary hyperparathyroidism and their relationship with bone mineral density"
by: Piedra María, et al.
Published: (2011-12-01)